Valuation: ResMed, Inc.

Market Cap 2.92TCr 2.56TCr 2.36TCr 2.17TCr 4.11TCr 2,81800Cr 4.18TCr 28TCr 11TCr 1,37600Cr 11TCr 11TCr 4,75100Cr P/E 2026 *
19.2x
P/E 2027 * 17.4x
Enterprise Value 2.85TCr 2.49TCr 2.3TCr 2.11TCr 4TCr 2,74300Cr 4.07TCr 27TCr 11TCr 1,33900Cr 11TCr 10TCr 4,62400Cr EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.61x
Free-Float
75.61%
Yield 2026 *
1.2%
Yield 2027 * 1.3%
1 day+2.11%
1 week-2.73%
Current month+4.04%
1 month+4.55%
3 months-9.77%
6 months-21.28%
Current year-15.82%
1 week 190.25
Extreme 190.25
203.88
1 month 187.01
Extreme 187.01
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%-2.73%-20.25%-8.81% 2.92TCr
+1.48%+3.52%+30.48%+2.61% 20TCr
+2.10%+4.61%+6.06%-14.77% 15TCr
+3.43%-2.24%-21.52%+13.65% 14TCr
+3.67%-0.82%-56.76%-15.86% 6.63TCr
+0.65%-3.82%+15.37%-5.93% 5.06TCr
+1.18%+2.27%-23.75%-31.97% 4.48TCr
+1.03%+1.88%+19.99%+13.65% 3.84TCr
+0.87%+0.28%+30.61%+39.67% 3.71TCr
+3.96%+1.55%-12.92%-19.70% 2.99TCr
Average +1.63%+0.67%-3.27%-2.74% 7.86TCr
Weighted average by Cap. +1.78%+1.63%+1.07%-1.66%

Financials

2026 *2027 *
Net sales 564.98Cr 493.85Cr 456.71Cr 419.09Cr 793.18Cr 54TCr 806.96Cr 5.45TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 602.45Cr 526.6Cr 487Cr 446.88Cr 845.78Cr 58TCr 860.47Cr 5.81TCr 2.28TCr 28TCr 2.26TCr 2.21TCr 98TCr
Net income 154.66Cr 135.18Cr 125.02Cr 114.72Cr 217.12Cr 15TCr 220.9Cr 1.49TCr 585.7Cr 7.28TCr 580.8Cr 568.04Cr 25TCr 167.11Cr 146.07Cr 135.09Cr 123.96Cr 234.61Cr 16TCr 238.69Cr 1.61TCr 632.87Cr 7.86TCr 627.57Cr 613.79Cr 27TCr
Net Debt -78Cr -68Cr -63Cr -58Cr -109.98Cr -7.55TCr -111.89Cr -755.19Cr -296.66Cr -3.69TCr -294.18Cr -287.72Cr -13TCr -145.68Cr -127.34Cr -117.77Cr -108.07Cr -204.53Cr -14TCr -208.08Cr -1.4TCr -551.72Cr -6.86TCr -547.11Cr -535.09Cr -24TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
16/26/16 $202.76 +2.11% 10,19,540
15/26/15 $198.57 +2.88% 12,08,785
14/26/14 $193.01 -2.77% 16,22,359
13/26/13 $198.50 -2.63% 21,61,420
10/26/10 $203.87 -2.20% 13,31,149
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
202.76USD
Average target price
249.40USD
Spread / Average Target
+23.00%

Quarterly revenue - Rate of surprise